Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    Battelle Wins CBRNE Contract from CENTCOM

    By Global Biodefense StaffOctober 28, 2014
    CBRNE Troops from CENTCOM
    Share
    Facebook LinkedIn Reddit Email

    Experts from Battelle will now provide on-site support at U.S. Central Command (CENTOM) headquarters at MacDill Air Force Base in Tampa, Fl., helping in their critical mission to Counter Weapons of Mass Destruction and to mitigate Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE) threats in the Middle East.

    Battelle recently was awarded a $6 million, three-year contract to provide these Countering-WMD Defense services. The work includes WMD analysis; technical and administrative support to integrate and synchronize nonproliferation, counter proliferation and consequence management activities involving policy, doctrine, planning, intelligence, strategy, exercises, operations and host nation readiness-related issues.

    “For the past several decades, Battelle has helped government agencies and industries solve some of their most complex CBRNE defense challenges,” said Matt Shaw, general manager of Battelle’s CBRNE business. “We are proud that our clients recognize our deep-rooted expertise and want to take full advantage of this reservoir of knowledge.”

    Battelle is headquartered in Columbus, Ohio and provides expert services in national security, health and life sciences, and energy and environmental industries. Battelle introduced the Resource Effective BioIdentification System (REBS) in early 2014, a next-generation biodefense sensor system. The organization also recently announced an Integrated Solution for Incident Response, and a government contract award for comprehensive Study of Forensic DNA Tools.

    Battelle is an official sponsor of Global Biodefense.

    Awards Battelle CBRN Equipment Collective Protection Consequence Management Individual Protection
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNew Hope for Drug Discovery in African Sleeping Sickness
    Next Article ADI Offers Ebola ELISA Test Kits for Humans and Animals

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy